PHARMACEUTICALLY ELEGANT
LIVE

Serial Number

99208694

Owner

Aquestive Therapeutics, Inc.

Attorney

Carrie Webb Olson

Filing Date

May 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PHARMACEUTICALLY ELEGANT Trademark

Serial Number: 99208694

PHARMACEUTICALLY ELEGANT is a trademark filed by Aquestive Therapeutics, Inc. on May 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Aquestive Therapeutics, Inc.

30 Technology Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 29, 2025

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches

Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 29, 2025 MAFR
NEW APPLICATION ENTERED
May 29, 2025 NWAP